These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 29951892)

  • 1. The microRNA signatures: aberrantly expressed miRNAs in prostate cancer.
    Sharma N; Baruah MM
    Clin Transl Oncol; 2019 Feb; 21(2):126-144. PubMed ID: 29951892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
    Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of microRNA signature and potential pathway targets in prostate cancer.
    Moustafa AA; Ziada M; Elshaikh A; Datta A; Kim H; Moroz K; Srivastav S; Thomas R; Silberstein JL; Moparty K; Salem FE; El-Habit OH; Abdel-Mageed AB
    Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
    Kumar B; Lupold SE
    Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.
    Zhang W; Zang J; Jing X; Sun Z; Yan W; Yang D; Shen B; Guo F
    J Transl Med; 2014 Mar; 12():66. PubMed ID: 24618011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression profile analysis reveals diagnostic biomarker for human prostate cancer.
    Liu DF; Wu JT; Wang JM; Liu QZ; Gao ZL; Liu YX
    Asian Pac J Cancer Prev; 2012; 13(7):3313-7. PubMed ID: 22994753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in prostate cancer: From function to biomarker discovery.
    Moustafa AA; Kim H; Albeltagy RS; El-Habit OH; Abdel-Mageed AB
    Exp Biol Med (Maywood); 2018 Jun; 243(10):817-825. PubMed ID: 29932371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep sequencing of small RNA libraries from human prostate epithelial and stromal cells reveal distinct pattern of microRNAs primarily predicted to target growth factors.
    Singh S; Zheng Y; Jagadeeswaran G; Ebron JS; Sikand K; Gupta S; Sunker R; Shukla GC
    Cancer Lett; 2016 Feb; 371(2):262-73. PubMed ID: 26655274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
    Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
    Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA biogenesis, gene silencing mechanisms and role in breast, ovarian and prostate cancer.
    Khan S; Ayub H; Khan T; Wahid F
    Biochimie; 2019 Dec; 167():12-24. PubMed ID: 31493469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of microRNA dysregulation in the development of prostate cancer.
    Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
    Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
    Bertoli G; Cava C; Castiglioni I
    Int J Mol Sci; 2016 Mar; 17(3):421. PubMed ID: 27011184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer.
    Ghafouri-Fard S; Shoorei H; Taheri M
    Gene; 2020 Oct; 759():144995. PubMed ID: 32721477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating differential miRNA expression profiling using serum and urine specimens for detecting potential biomarkers for early prostate cancer diagnosis.
    Hasanoğlu S; Göncü B; Yücesan E; Atasoy S; Kayalı Y; Özten Kandaş N
    Turk J Med Sci; 2021 Aug; 51(4):1764-1774. PubMed ID: 33550766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs Role in Prostate Cancer.
    Balacescu O; Dumitrescu RG; Marian C
    Methods Mol Biol; 2018; 1856():103-117. PubMed ID: 30178248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin A regulates microRNAs and gene expression in LNCaP cells.
    Ottley EC; Nicholson HD; Gold EJ
    Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory microRNA networks: complex patterns of target pathways for disease-related and housekeeping microRNAs.
    Zafari S; Backes C; Leidinger P; Meese E; Keller A
    Genomics Proteomics Bioinformatics; 2015 Jun; 13(3):159-68. PubMed ID: 26169798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.